{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:16:13Z","timestamp":1787026573313,"version":"build-2736575974"},"reference-count":274,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Severe fever with thrombocytopenia syndrome (SFTS), caused by the SFTS virus (SFTSV), has emerged as a significant global public health threat. Infected patients may present with gastrointestinal, neurological, and cardiovascular ribavirin and favipiravir are currently used in clinical practice, their efficacy remains controversial, and treatment primarily relies on symptomatic and supportive care. To date, there is no standard treatment regimen for SFTSV infection, nor are there any approved vaccines. However, recent advances in SFTSV research and the application of novel technologies have opened new pathways for the development of antiviral drugs and vaccines. This review summarizes the latest progress in the development of therapeutic agents and vaccines against SFTSV, aiming to provide valuable insights for drug development and countermeasure strategies for SFTS.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1730089","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T06:39:54Z","timestamp":1769495994000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Research progress on antiviral drugs and vaccines for severe fever with thrombocytopenia syndrome"],"prefix":"10.3389","volume":"17","author":[{"given":"Chendan","family":"Chen","sequence":"first","affiliation":[{"name":"Zhejiang Key Laboratory of Public Health Detection and Pathogenesis Research, Department of Microbiology, Zhejiang Provincial Center for Disease Control Prevention","place":["Hangzhou, China"]},{"name":"School of Laboratory Medicine and Life Sciences, Wenzhou Medical University","place":["Wenzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Li","sequence":"additional","affiliation":[{"name":"Zhejiang Key Laboratory of Public Health Detection and Pathogenesis Research, Department of Microbiology, Zhejiang Provincial Center for Disease Control Prevention","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxuan","family":"Li","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Zhejiang Chinese Medical University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renjin","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Laboratory Medicine and Life Sciences, Wenzhou Medical University","place":["Wenzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghao","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghan","family":"Xu","sequence":"additional","affiliation":[{"name":"Zhejiang Key Laboratory of Public Health Detection and Pathogenesis Research, Department of Microbiology, Zhejiang Provincial Center for Disease Control Prevention","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Zhejiang Key Laboratory of Public Health Detection and Pathogenesis Research, Department of Microbiology, Zhejiang Provincial Center for Disease Control Prevention","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongliang","family":"Lou","sequence":"additional","affiliation":[{"name":"School of Laboratory Medicine and Life Sciences, Wenzhou Medical University","place":["Wenzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"B1","unstructured":"Virus Taxonomy: 2022 Release, GenusBandavirus\n          \n          2024"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1010095","article-title":"Fever with thrombocytopenia associated with a novel bunyavirus in China","volume":"364","author":"Yu","year":"2011","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3201\/eid2505.181463","article-title":"Endemic severe fever with thrombocytopenia syndrome, Vietnam","volume":"25","author":"Tran","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3201\/eid1911.130792","article-title":"Severe fever with thrombocytopenia syndrome, South Korea, 2012","volume":"19","author":"Kim","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2019.1710436","article-title":"The first discovery of severe fever with thrombocytopenia syndrome virus in Taiwan","volume":"9","author":"Lin","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit603","article-title":"The first identification and retrospective study of severe fever with thrombocytopenia syndrome in Japan","volume":"209","author":"Takahashi","year":"2014","journal-title":"J Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.virs.2024.04.001","article-title":"Risk of infection with arboviruses in a healthy population in Pakistan based on seroprevalence","volume":"39","author":"Chen","year":"2024","journal-title":"Virol Sin"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1203378","article-title":"A new phlebovirus associated with severe febrile illness in missouri","volume":"367","author":"McMullan","year":"2012","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41426-018-0093-2","article-title":"A novel tick-borne phlebovirus, closely related to severe fever with thrombocytopenia syndrome virus and Heartland virus, is a potential pathogen","volume":"7","author":"Shen","year":"2018","journal-title":"Emerg Microbes Infect"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis472","article-title":"Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients","volume":"206","author":"Gai","year":"2012","journal-title":"J Infect Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s12985-024-02564-y","article-title":"Pathogen isolation and traceability analysis of a fatal case of severe fever with thrombocytopenia syndrome virus (SFTSV) infectious encephalitis in China","volume":"21","author":"Liu","year":"2024","journal-title":"Virol J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1111\/bjh.19364","article-title":"Prolonged coagulation times in severe fever with thrombocytopenia syndrome virus infection, the indicators of heparin-like effect and increased haemorrhagic risk","volume":"204","author":"Tang","year":"2024","journal-title":"Br J Haematol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12985-018-1006-7","article-title":"Multiple organ involvement in severe fever with thrombocytopenia syndrome: an immunohistochemical finding in a fatal case","volume":"15","author":"Li","year":"2018","journal-title":"Virol J"},{"key":"B14","unstructured":"World Health Organization (WHO): 2017 - First Annual review of diseases prioritized under the Research and Development Blueprint\n          \n          2017"},{"key":"B15","doi-asserted-by":"publisher","first-page":"101747","DOI":"10.1016\/j.lanwpc.2025.101747","article-title":"Comprehensive epidemiological analysis of severe fever with thrombocytopenia syndrome in Japan, 2013\u20132023: descriptive observational study","volume":"65","author":"Ohno","year":"2025","journal-title":"Lancet Reg Health - West Pac"},{"key":"B16","unstructured":"First fatality from Severe Fever with Thrombocytopenia Syndrome (SFTS) this year\n          \n          2024"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.16250\/j.32.1915.2024288","article-title":"Epidemic characteristics of fatal cases of severe fever with thrombocytopenia syndrome in China from 2010 to 2023","volume":"22","author":"Yue","year":"2024","journal-title":"J Trop Dis Parasitol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"101133","DOI":"10.1016\/j.lanwpc.2024.101133","article-title":"Global epidemiology of severe fever with thrombocytopenia syndrome virus in human and animals: a systematic review and meta-analysis","volume":"48","author":"Cui","year":"2024","journal-title":"Lancet Reg Health - West Pac"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1561","article-title":"Epidemiology and ecology of severe fever with thrombocytopenia syndrome in China, 2010\u20132018","volume":"73","author":"Miao","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s13071-024-06341-2","article-title":"Comprehensive meta-analysis of severe fever with thrombocytopenia syndrome virus infections in humans, vertebrate hosts and questing ticks","volume":"17","author":"Xu","year":"2024","journal-title":"Parasit Vectors"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e0013304","DOI":"10.1371\/journal.pntd.0013304","article-title":"Contributions of different host species to the natural transmission of severe fever with thrombocytopenia syndrome virus in China. Cho NH, editor","volume":"19","author":"Cheng","year":"2025","journal-title":"PloS Negl Trop Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.08.008","article-title":"Human-to-human transmission of severe fever with thrombocytopenia syndrome virus through potential ocular exposure to infectious blood","volume":"123","author":"Wu","year":"2022","journal-title":"Int J Infect Dis IJID Off Publ Int Soc Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"101271","DOI":"10.1016\/j.lanmic.2025.101271","article-title":"Epidemic potential of SFTSV: increasing evidence for non-vector-borne transmission","author":"Zheng","year":"2025","journal-title":"Lancet Microbe"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e0013283","DOI":"10.1371\/journal.pntd.0013283","article-title":"Epidemiological characteristics of human-to-human transmission of severe fever with thrombocytopenia syndrome in China from 1996 to 2023. Zinszer K, editor","volume":"19","author":"Yuan","year":"2025","journal-title":"PloS Negl Trop Dis"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1708979","article-title":"Pathogen spectrum, clinical traits and exploration of mortality outcome-improving medication regimens in coinfection patients with severe fever with thrombocytopenia syndrome: a multicenter cohort study","volume":"15","author":"Fan","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"6333","DOI":"10.1038\/s41467-023-41804-7","article-title":"Cryo-EM structure of severe fever with thrombocytopenia syndrome virus","volume":"14","author":"Du","year":"2023","journal-title":"Nat Commun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa253","article-title":"Structural and functional characterization of the severe fever with thrombocytopenia syndrome virus L protein","volume":"48","author":"Vogel","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.epidem.2012.09.002","article-title":"Evolutionary and molecular analysis of the emergent severe fever with thrombocytopenia syndrome virus","volume":"5","author":"Lam","year":"2013","journal-title":"Epidemics"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e0151677","DOI":"10.1371\/journal.pone.0151677","article-title":"Molecular evolution and spatial transmission of severe fever with thrombocytopenia syndrome virus based on complete genome sequences. Xing Z, editor","volume":"11","author":"Liu","year":"2016","journal-title":"PloS One"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e3237","DOI":"10.1371\/journal.pntd.0003237","article-title":"The evolutionary history and spatiotemporal dynamics of the fever, thrombocytopenia and leukocytopenia syndrome virus (FTLSV) in China. Aguilar PV, editor","volume":"8","author":"Huang","year":"2014","journal-title":"PloS Negl Trop Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"19563","DOI":"10.1038\/srep19563","article-title":"Phylogeographic analysis of severe fever with thrombocytopenia syndrome virus from Zhoushan Islands, China: implication for transmission across the ocean","volume":"6","author":"Fu","year":"2016","journal-title":"Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.meegid.2015.12.022","article-title":"Molecular evolution of fever, thrombocytopenia and leukocytopenia virus (FTLSV) based on whole-genome sequences","volume":"39","author":"Liu","year":"2016","journal-title":"Infect Genet Evol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01317-12","article-title":"Discovery of severe fever with thrombocytopenia syndrome bunyavirus strains originating from intragenic recombination","volume":"86","author":"He","year":"2012","journal-title":"J Virol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv144","article-title":"Phylogenetic and geographic relationships of severe fever with thrombocytopenia syndrome virus in China, South Korea, and Japan","volume":"212","author":"Yoshikawa","year":"2015","journal-title":"J Infect Dis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2022.2081617","article-title":"Effect of genomic variations in severe fever with thrombocytopenia syndrome virus on the disease lethality","volume":"11","author":"Dai","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"B36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s12250-017-3953-3","article-title":"Isolation, characterization, and phylogenic analysis of three new severe fever with thrombocytopenia syndrome bunyavirus strains derived from Hubei Province, China","volume":"32","author":"Zhang","year":"2017","journal-title":"Virol Sin"},{"key":"B37","doi-asserted-by":"publisher","first-page":"veae054","DOI":"10.1093\/ve\/veae054","article-title":"Deciphering the evolutionary landscape of severe fever with thrombocytopenia syndrome virus across East Asia","volume":"10","author":"Park","year":"2024","journal-title":"Virus Evol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e0011654","DOI":"10.1371\/journal.pntd.0011654","article-title":"Extensive genetic diversity of severe fever with thrombocytopenia syndrome virus circulating in Hubei Province, China, 2018\u20132022. Escalante AA, editor","volume":"17","author":"Ren","year":"2023","journal-title":"PloS Negl Trop Dis"},{"key":"B39","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3390\/microorganisms13020292","article-title":"Analysis of gene differences between F and B epidemic lineages of bandavirus dabieense","volume":"13","author":"Ma","year":"2025","journal-title":"Microorganisms"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e0318742","DOI":"10.1371\/journal.pone.0318742","article-title":"Whole-genome sequence analysis of SFTS bunyavirus in Huzhou, China. Ho PL, editor","volume":"20","author":"Xu","year":"2025","journal-title":"PloS One"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112150-20221130-01162","article-title":"The epidemiology and pathogeny investigation of two clusters of severe fever with thrombocytopenia syndrome disease outbreaking in Henan Province, 2022","volume":"57","author":"Li","year":"2023","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"B42","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2220\/biomedres.38.89","article-title":"The amino acid at position 624 in the glycoprotein of SFTSV (severe fever with thrombocytopenia virus) plays a critical role in low-pH-dependent cell fusion activity","volume":"38","author":"Tsuda","year":"2017","journal-title":"BioMed Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/msae173\/7742746","article-title":"Ecological Changes Exacerbating the Spread of Invasive Ticks has Driven the Dispersal of Severe Fever with Thrombocytopenia Syndrome Virus Throughout Southeast Asia. Stern A, editor","volume":"41","author":"P\u00e9rez","year":"2024","journal-title":"Mol Biol Evol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00612-12","article-title":"Suppression of the interferon and NF-\u03baB responses by severe fever with thrombocytopenia syndrome virus","volume":"86","author":"Qu","year":"2012","journal-title":"J Virol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ijid.2015.12.009","article-title":"Decreased monocyte subsets and TLR4-mediated functions in patients with acute severe fever with thrombocytopenia syndrome (SFTS)","volume":"43","author":"Peng","year":"2016","journal-title":"Int J Infect Dis IJID Off Publ Int Soc Infect Dis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"110039","DOI":"10.1016\/j.celrep.2021.110039","article-title":"Single-cell landscape of peripheral immune responses to fatal SFTS","volume":"37","author":"Li","year":"2021","journal-title":"Cell Rep"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e22722","DOI":"10.1096\/fj.202201343RR","article-title":"CD8(+) T cells mediate antiviral response in severe fever with thrombocytopenia syndrome","volume":"37","author":"Zong","year":"2023","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1172\/JCI129171","article-title":"Severe fever with thrombocytopenia syndrome virus targets B cells in lethal human infections","volume":"130","author":"Suzuki","year":"2020","journal-title":"J Clin Invest"},{"key":"B49","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1038\/s41467-018-05746-9","article-title":"Deficient humoral responses and disrupted B-cell immunity are associated with fatal SFTSV infection","volume":"9","author":"Song","year":"2018","journal-title":"Nat Commun"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e70741","DOI":"10.1002\/jmv.70741","article-title":"Dysregulated B cell responses in severe fever with thrombocytopenia syndrome revealed by single-cell RNA sequencing","volume":"97","author":"Hou","year":"2025","journal-title":"J Med Virol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02277-13","article-title":"The pathogenesis of severe fever with thrombocytopenia syndrome virus infection in alpha\/beta interferon knockout mice: insights into the pathologic mechanisms of a new viral hemorrhagic fever","volume":"88","author":"Liu","year":"2014","journal-title":"J Virol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02628-12","article-title":"Severe fever with thrombocytopenia virus glycoproteins are targeted by neutralizing antibodies and can use DC-SIGN as a receptor for pH-dependent entry into human and animal cell lines","volume":"87","author":"Hofmann","year":"2013","journal-title":"J Virol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"eadg6856","DOI":"10.1126\/sciadv.adg6856","article-title":"CCR2 is a host entry receptor for severe fever with thrombocytopenia syndrome virus","volume":"9","author":"Zhang","year":"2023","journal-title":"Sci Adv"},{"key":"B54","doi-asserted-by":"publisher","first-page":"4036","DOI":"10.1038\/s41467-025-59305-0","article-title":"Genome-wide CRISPR screening identifies LRP1 as an entry factor for SFTSV","volume":"16","author":"Xing","year":"2025","journal-title":"Nat Commun"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02141-13","article-title":"Nonmuscle myosin heavy chain\u00a0IIA is a critical factor contributing to the efficiency of early infection of severe fever with thrombocytopenia syndrome virus","volume":"88","author":"Sun","year":"2014","journal-title":"J Virol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"106004","DOI":"10.1016\/j.antiviral.2024.106004","article-title":"M\u03b2CD inhibits SFTSV entry by disrupting lipid raft structure of the host cells","volume":"231","author":"Cheng","year":"2024","journal-title":"Antiviral Res"},{"key":"B57","doi-asserted-by":"publisher","first-page":"104926","DOI":"10.1016\/j.antiviral.2020.104926","article-title":"Activation of platelet-derived growth factor receptor \u03b2 in the severe fever with thrombocytopenia syndrome virus infection","volume":"182","author":"Tani","year":"2020","journal-title":"Antiviral Res"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e1006316","DOI":"10.1371\/journal.ppat.1006316","article-title":"A role for glycolipid biosynthesis in severe fever with thrombocytopenia syndrome virus entry","volume":"13","author":"Drake","year":"2017","journal-title":"PloS Pathog"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s12250-019-00141-0","article-title":"SNX11 identified as an essential host factor for SFTS virus infection by CRISPR knockout screening","volume":"34","author":"Liu","year":"2019","journal-title":"Virol Sin"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1120246109","article-title":"Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57\/BL6 mouse model","volume":"109","author":"Jin","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2023.02.006","article-title":"Severe fever with thrombocytopenia syndrome virus replicates in platelets and enhances platelet activation","volume":"21","author":"Fang","year":"2023","journal-title":"J Thromb Haemost JTH"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e0011488","DOI":"10.1371\/journal.pntd.0011488","article-title":"Dabie bandavirus infection induces macrophagic pyroptosis and this process is attenuated by platelets","volume":"17","author":"Yu","year":"2023","journal-title":"PloS Negl Trop Dis"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiae355","article-title":"Thrombocytopenia in severe fever with thrombocytopenia syndrome due to platelets with altered function undergoing cell death pathways","volume":"231","author":"Fang","year":"2025","journal-title":"J Infect Dis"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA120.013973","article-title":"A RIG-I-like receptor directs antiviral responses to a bunyavirus and is antagonized by virus-induced blockade of TRIM25-mediated ubiquitination","volume":"295","author":"Min","year":"2020","journal-title":"J Biol Chem"},{"key":"B65","doi-asserted-by":"publisher","first-page":"590","DOI":"10.4049\/jimmunol.2100148","article-title":"Nonstructural Protein NSs Hampers Cellular Antiviral Response through LSm14A during Severe Fever with Thrombocytopenia Syndrome Virus Infection","volume":"207","author":"Zhang","year":"2021","journal-title":"J Immunol Baltim Md 1950"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mju015","article-title":"Viral suppression of innate immunity via spatial isolation of TBK1\/IKK\u03f5 from mitochondrial antiviral platform","volume":"6","author":"Ning","year":"2014","journal-title":"J Mol Cell Biol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2024.2356505","article-title":"Bunyavirus SFTSV NSs utilizes autophagy to escape the antiviral innate immune response","volume":"20","author":"Li","year":"2024","journal-title":"Autophagy"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800576","article-title":"Suppression of the IFN-\u03b1 and -\u03b2 Induction through Sequestering IRF7 into Viral Inclusion Bodies by Nonstructural Protein NSs in Severe Fever with Thrombocytopenia Syndrome Bunyavirus Infection","volume":"202","author":"Hong","year":"2019","journal-title":"J Immunol Baltim Md 1950"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00154-15","article-title":"Disruption of type I interferon signaling by the nonstructural protein of severe fever with thrombocytopenia syndrome virus via the hijacking of STAT2 and STAT1 into inclusion bodies","volume":"89","author":"Ning","year":"2015","journal-title":"J Virol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02226-18","article-title":"Species-specific pathogenicity of severe fever with thrombocytopenia syndrome virus is determined by anti-STAT2 activity of NSs","volume":"93","author":"Yoshikawa","year":"2019","journal-title":"J Virol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01182","article-title":"Interferon-\u03b3-directed inhibition of a novel high-pathogenic phlebovirus and viral antagonism of the antiviral signaling by targeting STAT1","volume":"10","author":"Ning","year":"2019","journal-title":"Front Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e0054220","DOI":"10.1128\/MCB.00542-20","article-title":"The nonstructural protein NSs of severe fever with thrombocytopenia syndrome virus causes a cytokine storm through the hyperactivation of NF-\u03baB","volume":"41","author":"Khalil","year":"2021","journal-title":"Mol Cell Biol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"11816","DOI":"10.1038\/srep11816","article-title":"Host responses and regulation by NF\u03baB signaling in the liver and liver epithelial cells infected with A novel tick-borne bunyavirus","volume":"5","author":"Sun","year":"2015","journal-title":"Sci Rep"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-018-0329-x","article-title":"Severe fever with thrombocytopenia syndrome phlebovirus non-structural protein activates TPL2 signalling pathway for viral immunopathogenesis","volume":"4","author":"Choi","year":"2019","journal-title":"Nat Microbiol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e2420245122","DOI":"10.1073\/pnas.2420245122","article-title":"A viral necrosome mediates direct RIPK3 activation to promote inflammatory necroptosis","volume":"122","author":"Li","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B76","doi-asserted-by":"publisher","first-page":"e1013258","DOI":"10.1371\/journal.ppat.1013258","article-title":"The non-structural protein of SFTSV activates NLRP1 and CARD8 inflammasome through disrupting the DPP9-mediated ternary complex. Mitchell P, editor","volume":"21","author":"Liu","year":"2025","journal-title":"PloS Pathog"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01575-19","article-title":"The severe fever with thrombocytopenia syndrome virus NSs protein interacts with CDK1 to induce G(2) cell cycle arrest and positively regulate viral replication","volume":"94","author":"Liu","year":"2020","journal-title":"J Virol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"e1010070","DOI":"10.1371\/journal.ppat.1010070","article-title":"SAFA initiates innate immunity against cytoplasmic RNA virus SFTSV infection","volume":"17","author":"Liu","year":"2021","journal-title":"PloS Pathog"},{"key":"B79","doi-asserted-by":"publisher","first-page":"e1013201","DOI":"10.1371\/journal.ppat.1013201","article-title":"SFTSV NSs degrades SAFA via autophagy to suppress SAFA-dependent antiviral response. Subbarao K, editor","volume":"21","author":"Yu","year":"2025","journal-title":"PloS Pathog"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2024.2393067","article-title":"Bunyavirus SFTSV nucleoprotein exploits TUFM-mediated mitophagy to impair antiviral innate immunity","volume":"21","author":"Zhang","year":"2025","journal-title":"Autophagy"},{"key":"B81","doi-asserted-by":"publisher","first-page":"e0379623","DOI":"10.1128\/spectrum.03796-23","article-title":"SFTSV nucleoprotein mediates DNA sensor cGAS degradation to suppress cGAS-dependent antiviral responses","volume":"12","author":"Jiang","year":"2024","journal-title":"Microbiol Spectr"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.595140","article-title":"SFTSV infection induced interleukin-1\u03b2 Secretion through NLRP3 inflammasome activation","volume":"12","author":"Liu","year":"2021","journal-title":"Front Immunol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1038\/s41598-022-06229-0","article-title":"Activation of the NLRP3 inflammasome and elevation of interleukin-1\u03b2 secretion in infection by sever fever with thrombocytopenia syndrome virus","volume":"12","author":"Li","year":"2022","journal-title":"Sci Rep"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.02.105","article-title":"SFTSV infection induces BAK\/BAX-dependent mitochondrial DNA release to trigger NLRP3 inflammasome activation","volume":"30","author":"Li","year":"2020","journal-title":"Cell Rep"},{"key":"B85","doi-asserted-by":"publisher","first-page":"e0016722","DOI":"10.1128\/jvi.00167-22","article-title":"Nonstructural protein NSs activates inflammasome and pyroptosis through interaction with NLRP3 in human microglial cells infected with severe fever with thrombocytopenia syndrome bandavirus","volume":"96","author":"Gao","year":"2022","journal-title":"J Virol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"e0181523","DOI":"10.1128\/jvi.01815-23","article-title":"Interaction between the SFTSV envelope glycoprotein Gn and STING inhibits the formation of the STING-TBK1 complex and suppresses the NF-\u03baB signaling pathway","volume":"98","author":"Jia","year":"2024","journal-title":"J Virol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.7150\/thno.50992","article-title":"Virus-induced p38 MAPK activation facilitates viral infection","volume":"10","author":"Cheng","year":"2020","journal-title":"Theranostics"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1046176","article-title":"Cyclophilin A causes severe fever with thrombocytopenia syndrome virus-induced cytokine storm by regulating mitogen-activated protein kinase pathway","volume":"13","author":"Huang","year":"2022","journal-title":"Front Microbiol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"5629","DOI":"10.1038\/s41467-021-25804-z","article-title":"A longitudinal sampling study of transcriptomic and epigenetic profiles in patients with thrombocytopenia syndrome","volume":"12","author":"Wang","year":"2021","journal-title":"Nat Commun"},{"key":"B90","doi-asserted-by":"publisher","first-page":"e1012725","DOI":"10.1371\/journal.ppat.1012725","article-title":"N6-methyladenosine RNA modification promotes Severe Fever with Thrombocytopenia Syndrome Virus infection. Ramage H, editor","volume":"20","author":"Chen","year":"2024","journal-title":"PloS Pathog"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1086\/375058","article-title":"The efficacy of oral ribavirin in the treatment of crimean-congo hemorrhagic fever in Iran","volume":"36","author":"Mardani","year":"2003","journal-title":"Clin Infect Dis"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1086\/657315","article-title":"Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for lassa fever","volume":"51","author":"Bausch","year":"2010","journal-title":"Clin Infect Dis"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1126\/science.177.4050.705","article-title":"Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide","volume":"177","author":"Sidwell","year":"1972","journal-title":"Science"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2.8.1317","article-title":"Ribavirin - current status of a broad spectrum antiviral agent","volume":"2","author":"Snell","year":"2001","journal-title":"Expert Opin Pharmacother"},{"key":"B95","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/rmv.483","article-title":"Mechanisms of action of ribavirin against distinct viruses","volume":"16","author":"Graci","year":"2006","journal-title":"Rev Med Virol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.7883\/yoken.67.423","article-title":"Effects of ribavirin on severe fever with thrombocytopenia syndrome virus in vitro","volume":"67","author":"Shimojima","year":"2014","journal-title":"Jpn J Infect Dis"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2016.109","article-title":"In vitro antiviral activity of ribavirin against severe fever with thrombocytopenia syndrome virus","volume":"32","author":"Lee","year":"2017","journal-title":"Korean J Intern Med"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3390\/v13061061","article-title":"M segment-based minigenome system of severe fever with thrombocytopenia syndrome virus as a tool for antiviral drug screening","volume":"13","author":"Yamada","year":"2021","journal-title":"Viruses"},{"key":"B99","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41392-021-00541-3","article-title":"Clinical effect and antiviral mechanism of T-705 in treating severe fever with thrombocytopenia syndrome","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B100","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.virol.2015.03.010","article-title":"Therapeutic effect of post-exposure treatment with antiserum on severe fever with thrombocytopenia syndrome (SFTS) in a mouse model of SFTS virus infection","volume":"482","author":"Shimada","year":"2015","journal-title":"Virology"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.19032","article-title":"Can antiviral drugs address the treatment challenges of severe fever with thrombocytopenia syndrome? - a systematic meta-analysis","volume":"18","author":"Shen","year":"2024","journal-title":"J Infect Dev Ctries"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit530","article-title":"Case-fatality ratio and effectiveness of ribavirin therapy among hospitalized patients in China who had severe fever with thrombocytopenia syndrome","volume":"57","author":"Liu","year":"2013","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3201\/eid2110.141928","article-title":"Characteristics and factors associated with death among patients hospitalized for severe fever with thrombocytopenia syndrome, South Korea, 2013","volume":"21","author":"Shin","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2013.08.011","article-title":"Plasma exchange and ribavirin for rapidly progressive severe fever with thrombocytopenia syndrome","volume":"18","author":"Oh","year":"2014","journal-title":"Int J Infect Dis IJID Off Publ Int Soc Infect Dis"},{"key":"B105","doi-asserted-by":"publisher","first-page":"e22131","DOI":"10.1002\/jca.22131","article-title":"Therapeutic plasma exchange combined with ribavirin to rescue critical SFTS patients","volume":"39","author":"Song","year":"2024","journal-title":"J Clin Apheresis"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1089\/vbz.2013.1421","article-title":"Early use of ribavirin is beneficial in crimean-congo hemorrhagic fever","volume":"14","author":"Ozbey","year":"2014","journal-title":"Vector-Borne Zoonotic Dis"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.29.6.1010","article-title":"Effect of ribavirin on macromolecular synthesis in vesicular stomatitis virus-infected cells","volume":"29","author":"Toltzis","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30293-7","article-title":"Epidemiological and clinical features of laboratory-diagnosed severe fever with thrombocytopenia syndrome in China, 2011\u201317: a prospective observational study","volume":"18","author":"Li","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26544","article-title":"Severe fever with thrombocytopenia syndrome in Hefei: Clinical features, risk factors, and ribavirin therapeutic efficacy","volume":"93","author":"Zhang","year":"2021","journal-title":"J\u00a0Med Virol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"e0011158","DOI":"10.1371\/journal.pntd.0011158","article-title":"A new model for predicting the outcome and effectiveness of drug therapy in patients with severe fever with thrombocytopenia syndrome: A multicenter Chinese study","volume":"17","author":"Xia","year":"2023","journal-title":"PloS Negl Trop Dis"},{"key":"B111","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.antiviral.2015.04.006","article-title":"Common adverse events associated with ribavirin therapy for Severe Fever with Thrombocytopenia Syndrome","volume":"119","author":"Lu","year":"2015","journal-title":"Antiviral Res"},{"key":"B112","doi-asserted-by":"publisher","first-page":"107512","DOI":"10.1016\/j.pharmthera.2020.107512","article-title":"Favipiravir, an anti-influenza drug against life-threatening RNA virus infections","volume":"209","author":"Shiraki","year":"2020","journal-title":"Pharmacol Ther"},{"key":"B113","doi-asserted-by":"publisher","first-page":"e0009103","DOI":"10.1371\/journal.pntd.0009103","article-title":"A multicenter non-randomized, uncontrolled single arm trial for evaluation of the efficacy and the safety of the treatment with favipiravir for patients with severe fever with thrombocytopenia syndrome","volume":"15","author":"Suemori","year":"2021","journal-title":"PloS Negl Trop Dis"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.3.981-986.2005","article-title":"Mechanism of action of T-705 against influenza virus","volume":"49","author":"Furuta","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00649-13","article-title":"Mechanism of action of T-705 ribosyl triphosphate against influenza virus RNA polymerase","volume":"57","author":"Sangawa","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01217-18","article-title":"Determining the mutation bias of favipiravir in influenza virus using next-generation sequencing","volume":"93","author":"Goldhill","year":"2019","journal-title":"J Virol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"26742","DOI":"10.1038\/srep26742","article-title":"Combinations of oseltamivir and T-705 extend the treatment window for highly pathogenic influenza A(H5N1) virus infection in mice","volume":"6","author":"Marathe","year":"2016","journal-title":"Sci Rep"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2013.09.015","article-title":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor","volume":"100","author":"Furuta","year":"2014","journal-title":"Antiviral Res"},{"key":"B119","doi-asserted-by":"publisher","first-page":"e0206416","DOI":"10.1371\/journal.pone.0206416","article-title":"Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: Dose-efficacy studies upon oral administration","volume":"13","author":"Tani","year":"2018","journal-title":"PloS One"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01942-16","article-title":"Modeling severe fever with thrombocytopenia syndrome virus infection in golden Syrian hamsters: importance of STAT2 in preventing disease and effective treatment with favipiravir","volume":"91","author":"Gowen","year":"2017","journal-title":"J Virol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00061-15","article-title":"Efficacy of T-705 (Favipiravir) in the treatment of infections with lethal severe fever with thrombocytopenia syndrome virus","volume":"1","author":"Tani","year":"2016","journal-title":"mSphere"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.virs.2024.08.007","article-title":"Antiviral activity of vitamin D derivatives against severe fever with thrombocytopenia syndrome virus in vitro and in vivo","volume":"39","author":"Luo","year":"2024","journal-title":"Virol Sin"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01062-25","article-title":"Efficacy of favipiravir treatment for patients with severe fever with thrombocytopenia syndrome assessed with a historical control. Odom John A, editor","volume":"69","author":"Saijo","year":"2025","journal-title":"Antimicrob Agents Chemother"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.4.977-981.2002","article-title":"In vitro and in vivo activities of anti-influenza virus compound T-705","volume":"46","author":"Furuta","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.839215","article-title":"Effective drugs against severe fever with thrombocytopenia syndrome virus in an in vitro model","volume":"9","author":"Bang","year":"2022","journal-title":"Front Med"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-019-01364-9","article-title":"Severe fever with thrombocytopenia syndrome (SFTS) treated with a novel antiviral medication, favipiravir (T-705)","volume":"48","author":"Song","year":"2020","journal-title":"Infection"},{"key":"B127","doi-asserted-by":"publisher","first-page":"103591","DOI":"10.1016\/j.ebiom.2021.103591","article-title":"Clinical efficacy and safety evaluation of favipiravir in treating patients with severe fever with thrombocytopenia syndrome","volume":"72","author":"Yuan","year":"2021","journal-title":"EBioMedicine"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.940178","article-title":"Dihydropyridine-derived calcium channel blocker as a promising anti-hantavirus entry inhibitor","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharmacol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1126\/science.1258758","article-title":"Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment","volume":"347","author":"Sakurai","year":"2015","journal-title":"Science"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku091","article-title":"The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry","volume":"69","author":"Gehring","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-019-0214-z","article-title":"Calcium channel blockers reduce severe fever with thrombocytopenia syndrome virus (SFTSV) related fatality","volume":"29","author":"Li","year":"2019","journal-title":"Cell Res"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.9052-21","article-title":"Successful recovery from severe fever with thrombocytopenia syndrome and hemophagocytic lymphohistiocytosis with standard treatment and a calcium channel blocker of nicardipine hydrochloride","volume":"62","author":"Yamauchi","year":"2023","journal-title":"Intern Med"},{"key":"B133","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3390\/v13050869","article-title":"Loperamide inhibits replication of severe fever with thrombocytopenia syndrome virus","volume":"13","author":"Urata","year":"2021","journal-title":"Viruses"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00015-23","article-title":"Calcium influx regulates the replication of\u00a0several negative-strand RNA viruses including severe fever with thrombocytopenia syndrome virus. Dutch RE, editor","volume":"97","author":"Urata","year":"2023","journal-title":"J Virol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.antiviral.2018.10.013","article-title":"2\u2019-Fluoro-2\u2019-deoxycytidine is a broad-spectrum inhibitor of bunyaviruses in vitro and in phleboviral disease mouse models","volume":"160","author":"Smee","year":"2018","journal-title":"Antiviral Res"},{"key":"B136","doi-asserted-by":"publisher","first-page":"104944","DOI":"10.1016\/j.ebiom.2023.104944","article-title":"A nanoluciferase SFTSV for rapid screening antivirals and real-time visualization of virus infection in mice","volume":"99","author":"Xu","year":"2024","journal-title":"EBioMedicine"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5c00626","article-title":"Design and development of a novel oral 4\u2019-fluorouridine double prodrug VV261 against SFTSV","volume":"68","author":"Cheng","year":"2025","journal-title":"J\u00a0Med Chem"},{"key":"B138","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2165\/00003088-200241020-00002","article-title":"Cellular and clinical pharmacology of fludarabine","volume":"41","author":"Gandhi","year":"2002","journal-title":"Clin\u00a0Pharmacokinet"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3390\/v13050774","article-title":"Fludarabine inhibits infection of zika virus, SFTS phlebovirus, and enterovirus A71","volume":"13","author":"Gao","year":"2021","journal-title":"Viruses"},{"key":"B140","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jiac.2018.03.005","article-title":"Caffeic acid, a coffee-related organic acid, inhibits infection by severe fever with thrombocytopenia syndrome virus in vitro","volume":"24","author":"Ogawa","year":"2018","journal-title":"J Infect Chemother"},{"key":"B141","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jiac.2020.10.015","article-title":"Structural basis of antiviral activity of caffeic acid against severe fever with thrombocytopenia syndrome virus","volume":"27","author":"Ogawa","year":"2021","journal-title":"J Infect Chemother"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2021.11.005","article-title":"L-DOPA, a treatment for Parkinson\u2019s disease, and its enantiomer D-DOPA inhibit severe fever with thrombocytopenia syndrome virus infection in vitro","volume":"28","author":"Ogawa","year":"2022","journal-title":"J Infect Chemother"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2023.02.017","article-title":"The combination of levodopa with levodopa-metabolizing enzyme inhibitors prevents severe fever with thrombocytopenia syndrome virus infection in vitro more effectively than single levodopa","volume":"29","author":"Ogawa","year":"2023","journal-title":"J Infect Chemother Off J Jpn Soc Chemother"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2020.08.005","article-title":"Several catechins and flavonols from green tea inhibit severe fever with thrombocytopenia syndrome virus infection in vitro","volume":"27","author":"Ogawa","year":"2021","journal-title":"J Infect Chemother"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-021-11094-4","article-title":"Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story","volume":"105","author":"Gasmi","year":"2021","journal-title":"Appl Microbiol Biotechnol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3390\/v8120322","article-title":"Chloroquine, an endocytosis blocking agent, inhibits zika virus infection in different cell models","volume":"8","author":"Delvecchio","year":"2016","journal-title":"Viruses"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2014.03.014","article-title":"Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity","volume":"106","author":"Boonyasuppayakorn","year":"2014","journal-title":"Antiviral Res"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2018.10.025","article-title":"Novel amodiaquine derivatives potently inhibit Ebola virus infection","volume":"160","author":"Sakurai","year":"2018","journal-title":"Antiviral Res"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1177\/2040206617740303","article-title":"Establishment of an antiviral assay system and identification of severe fever with\u00a0thrombocytopenia syndrome virus inhibitors","volume":"25","author":"Baba","year":"2017","journal-title":"Antivir Chem Chemother"},{"key":"B150","doi-asserted-by":"publisher","first-page":"105479","DOI":"10.1016\/j.antiviral.2022.105479","article-title":"Amodiaquine derivatives as inhibitors of severe fever with thrombocytopenia syndrome virus (SFTSV) replication","volume":"210","author":"Baba","year":"2023","journal-title":"Antiviral Res"},{"key":"B151","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3390\/v11040385","article-title":"Screening of an FDA-approved drug library with a two-tier system identifies an entry inhibitor of severe fever with thrombocytopenia syndrome virus","volume":"11","author":"Yuan","year":"2019","journal-title":"Viruses"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1973.tb00196.x","article-title":"Review of the toxicity of hexachlorophene, including its neurotoxicity","volume":"13","author":"Kimbrough","year":"1973","journal-title":"J Clin Pharmacol New Drugs"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1038\/nri3133","article-title":"Immunomodulatory functions of type I interferons","volume":"12","author":"Gonz\u00e1lez-Navajas","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s42826-020-00070-0","article-title":"Pathogenicity of severe fever with thrombocytopenia syndrome virus in mice regulated in type I interferon signaling: Severe fever with thrombocytopenia and type I interferon","volume":"36","author":"Park","year":"2020","journal-title":"Lab Anim Res"},{"key":"B155","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12985-024-02403-0","article-title":"Cytokines and lymphocyte subsets are associated with disease severity of severe fever with thrombocytopenia syndrome","volume":"21","author":"Song","year":"2024","journal-title":"Virol J"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2014.08.001","article-title":"Severe fever with thrombocytopenia syndrome bunyavirus-related human encephalitis","volume":"70","author":"Cui","year":"2015","journal-title":"J Infect"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-018-0317-1","article-title":"Ferret animal model of\u00a0severe fever with thrombocytopenia syndrome phlebovirus for human lethal infection and pathogenesis","volume":"4","author":"Park","year":"2019","journal-title":"Nat Microbiol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S444398","article-title":"Changes in cytokine levels in patients with severe fever with thrombocytopenia syndrome virus","volume":"17","author":"Xu","year":"2024","journal-title":"J\u00a0Inflammation Res"},{"key":"B159","doi-asserted-by":"publisher","first-page":"2587374","DOI":"10.1080\/21505594.2025.2587374","article-title":"Severe fever with thrombocytopenia syndrome virus infection induces thymic atrophy in IFNAR\u2013\/\u2013 mice","volume":"16","author":"Ma","year":"2025","journal-title":"Virulence"},{"key":"B160","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12916-024-03421-z","article-title":"Ruxolitinib plus standard of care in severe hospitalized adults with severe fever with thrombocytopenia syndrome (SFTS): an exploratory, single-arm trial","volume":"22","author":"Wen","year":"2024","journal-title":"BMC Med"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1007\/s12250-019-00162-9","article-title":"Proteasome inhibitor PS-341 effectively blocks infection by the severe fever with thrombocytopenia syndrome virus","volume":"34","author":"Liu","year":"2019","journal-title":"Virol Sin"},{"key":"B162","doi-asserted-by":"publisher","first-page":"106141","DOI":"10.1016\/j.antiviral.2025.106141","article-title":"Kaempferide enhances type I interferon signaling as a novel broad-spectrum antiviral agent","volume":"237","author":"Du","year":"2025","journal-title":"Antiviral Res"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.4014\/jmb.2008.08048","article-title":"Nonstructural protein of severe fever with thrombocytopenia syndrome phlebovirus inhibits TBK1 to evade interferon-mediated response","volume":"31","author":"Lee","year":"2021","journal-title":"J\u00a0Microbiol Biotechnol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00706-18","article-title":"Two conserved amino acids within the NSs of severe fever with thrombocytopenia syndrome phlebovirus are essential for anti-interferon activity","volume":"92","author":"Moriyama","year":"2018","journal-title":"J Virol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"102307","DOI":"10.1016\/j.ttbdis.2023.102307","article-title":"Downregulation of transcription 1 hinders the replication of Dabie bandavirus by promoting the expression of TLR7, TLR8, and TLR9 signaling pathway","volume":"15","author":"An","year":"2024","journal-title":"Ticks Tick-Borne Dis"},{"key":"B166","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13256-016-1192-0","article-title":"Unusual presentation of a severely ill patient having severe fever with thrombocytopenia syndrome: a case report","volume":"11","author":"Kaneko","year":"2017","journal-title":"J Med Case Rep"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1111\/pin.12207","article-title":"Two autopsy cases of severe fever with thrombocytopenia syndrome (SFTS) in Japan: a pathognomonic histological feature and unique complication of SFTS","volume":"64","author":"Hiraki","year":"2014","journal-title":"Pathol Int"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.07.001","article-title":"Effects of corticosteroid treatment in patients with severe fever with thrombocytopenia syndrome: A single-center retrospective cohort study","author":"Xiong","year":"2022","journal-title":"Int J Infect Dis IJID Off Publ Int Soc Infect Dis"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2017.11.004","article-title":"Steroid pulse therapy in patients with encephalopathy associated with severe fever with thrombocytopenia syndrome","volume":"24","author":"Nakamura","year":"2018","journal-title":"J Infect Chemother Off J Jpn Soc Chemother"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S478520","article-title":"Impact of glucocorticoid therapy on 28-day mortality in patients having severe fever with thrombocytopenia syndrome in an intensive care unit: A retrospective analysis","volume":"17","author":"Wang","year":"2024","journal-title":"J Inflammation Res"},{"key":"B171","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.3390\/v16121906","article-title":"Analysis of changes in viral load and inflammatory cytokines, as well as the occurrence of secondary infections, in SFTS patients treated with specific treatments: A prospective multicenter cohort study","volume":"16","author":"Seo","year":"2024","journal-title":"Viruses"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S505421","article-title":"Time-varying effects of glucocorticoid treatment in critically III patients with severe fever with thrombocytopenia syndrome: an inverse probability of treatment weighting analysis","volume":"18","author":"Xia","year":"2025","journal-title":"J Inflammation Res"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2023.03.015","article-title":"Clinical efficacy of low-dose glucocorticoid therapy for critically ill patients with severe fever with thrombocytopenia syndrome: A retrospective cohort study","volume":"130","author":"Wang","year":"2023","journal-title":"Int J Infect Dis IJID Off Publ Int Soc Infect Dis"},{"key":"B174","doi-asserted-by":"publisher","first-page":"104807","DOI":"10.1016\/j.ebiom.2023.104807","article-title":"Clinical efficacy of immunoglobulin on the treatment of severe fever with thrombocytopenia syndrome: a retrospective cohort study","volume":"96","author":"Zhang","year":"2023","journal-title":"EBioMedicine"},{"key":"B175","doi-asserted-by":"publisher","first-page":"pgac024","DOI":"10.1093\/pnasnexus\/pgac024","article-title":"Exploration of immunological responses underpinning severe fever with thrombocytopenia syndrome virus infection reveals IL-6 as a therapeutic target in an immunocompromised mouse model","volume":"1","author":"Bryden","year":"2022","journal-title":"PNAS Nexus"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2024.0209","article-title":"Tocilizumab for patients with severe fever with thrombocytopenia syndrome: tocilizumab observational SFTS study-1","volume":"66","author":"Yoo","year":"2025","journal-title":"Yonsei Med J"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00858-w","article-title":"Antiviral neutralizing antibodies: from in vitro to in vivo activity","volume":"23","author":"Burton","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2023.05.018","article-title":"Dynamics of neutralizing antibodies against severe fever with thrombocytopenia syndrome virus","author":"Li","year":"2023","journal-title":"Int J Infect Dis"},{"key":"B179","doi-asserted-by":"publisher","first-page":"e38291","DOI":"10.1371\/journal.pone.0038291","article-title":"Critical epitopes in the nucleocapsid protein of SFTS virus recognized by a panel of SFTS patients derived human monoclonal antibodies","volume":"7","author":"Yu","year":"2012","journal-title":"PloS One"},{"key":"B180","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12985-023-02173-1","article-title":"Antibody production and characterization of the nucleoprotein of sever fever with thrombocytopenia syndrome virus (SFTSV) for effective diagnosis of SFTSV","volume":"20","author":"Lee","year":"2023","journal-title":"Virol J"},{"key":"B181","doi-asserted-by":"publisher","first-page":"e0004595","DOI":"10.1371\/journal.pntd.0004595","article-title":"Severe fever with thrombocytopenia syndrome virus antigen detection using monoclonal antibodies to the nucleocapsid protein. Michael SF, editor","volume":"10","author":"Fukuma","year":"2016","journal-title":"PloS Negl Trop Dis"},{"key":"B182","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/molecules30010038","article-title":"Development of 111In-labeled monoclonal antibodies targeting SFTSV structural proteins for molecular imaging of SFTS infectious diseases by SPECT","volume":"30","author":"Fuchigami","year":"2024","journal-title":"Molecules"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1705176114","article-title":"Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitope","volume":"114","author":"Wu","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"B184","doi-asserted-by":"publisher","first-page":"e2400163121","DOI":"10.1073\/pnas.2400163121","article-title":"Bispecific antibodies targeting two glycoproteins on SFTSV exhibit synergistic neutralization and protection in a mouse model","volume":"121","author":"Chang","year":"2024","journal-title":"Proc Natl Acad Sci"},{"key":"B185","doi-asserted-by":"publisher","first-page":"7009","DOI":"10.1038\/s41467-024-51108-z","article-title":"A broadly protective antibody targeting glycoprotein Gn inhibits severe fever with thrombocytopenia syndrome virus infection","volume":"15","author":"Ren","year":"2024","journal-title":"Nat Commun"},{"key":"B186","doi-asserted-by":"publisher","first-page":"e0012216","DOI":"10.1371\/journal.pntd.0012216","article-title":"Identification and characterization of three monoclonal antibodies targeting the SFTSV glycoprotein and displaying a broad spectrum recognition of SFTSV-related viruses","volume":"18","author":"Wu","year":"2024","journal-title":"PloS Negl Trop Dis"},{"key":"B187","doi-asserted-by":"publisher","first-page":"e1012550","DOI":"10.1371\/journal.ppat.1012550","article-title":"Molecular mechanism and structure-guided humanization of a broadly neutralizing antibody against SFTSV","volume":"20","author":"Yang","year":"2024","journal-title":"PloS Pathog"},{"key":"B188","doi-asserted-by":"publisher","first-page":"105481","DOI":"10.1016\/j.ebiom.2024.105481","article-title":"Discovery and characterization of potent broadly neutralizing antibodies from human survivors of severe fever with thrombocytopenia syndrome","volume":"111","author":"Zhang","year":"2025","journal-title":"eBioMedicine"},{"key":"B189","doi-asserted-by":"publisher","first-page":"e1012889","DOI":"10.1371\/journal.ppat.1012889","article-title":"Pair combinations of human monoclonal antibodies fully protected mice against bunyavirus SFTSV lethal challenge","volume":"21","author":"Li","year":"2025","journal-title":"PloS Pathog"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00222-13","article-title":"Human antibody neutralizes severe Fever with thrombocytopenia syndrome virus, an emerging hemorrhagic Fever virus","volume":"20","author":"Guo","year":"2013","journal-title":"Clin Vaccine Immunol CVI"},{"key":"B191","doi-asserted-by":"publisher","first-page":"e1007375","DOI":"10.1371\/journal.ppat.1007375","article-title":"An anti-Gn glycoprotein antibody from a convalescent patient potently inhibits the infection of severe fever with thrombocytopenia syndrome virus","volume":"15","author":"Kim","year":"2019","journal-title":"PloS Pathog"},{"key":"B192","doi-asserted-by":"publisher","first-page":"113735","DOI":"10.1016\/j.jconrel.2025.113735","article-title":"The therapeutic potential of mRNA-encoded SFTSV human monoclonal antibody encapsulated lipid nanoparticle in vivo","volume":"382","author":"Lee","year":"2025","journal-title":"J Control Release Off J Control Release Soc"},{"key":"B193","doi-asserted-by":"publisher","first-page":"e4461","DOI":"10.1002\/pro.4461","article-title":"Development of functional anti-Gn nanobodies specific for SFTSV based on next-generation sequencing and proteomics","volume":"31","author":"Wang","year":"2022","journal-title":"Protein Sci Publ Protein Soc"},{"key":"B194","doi-asserted-by":"publisher","first-page":"136855","DOI":"10.1172\/jci.insight.136855","article-title":"A single-domain antibody inhibits SFTSV and mitigates virus-induced pathogenesis in vivo","volume":"5","author":"Wu","year":"2020","journal-title":"JCI Insight"},{"key":"B195","doi-asserted-by":"publisher","first-page":"e0079623","DOI":"10.1128\/jvi.00796-23","article-title":"Identification of tanshinone I as cap-dependent endonuclease inhibitor with broad-spectrum antiviral effect","volume":"97","author":"He","year":"2023","journal-title":"J Virol"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03289-24","article-title":"Development of FRET-based cap-snatching endonuclease assay","volume":"13","author":"Subbiah","year":"2025","journal-title":"Microbiol Spectr"},{"key":"B197","doi-asserted-by":"publisher","first-page":"e0217321","DOI":"10.1128\/jvi.02173-21","article-title":"Structural and biochemical basis for development of diketo acid inhibitors targeting the cap-snatching endonuclease of the ebinur lake virus (Order: bunyavirales)","volume":"96","author":"Kuang","year":"2022","journal-title":"J Virol"},{"key":"B198","doi-asserted-by":"publisher","first-page":"e0139924","DOI":"10.1128\/spectrum.01399-24","article-title":"Efficacy of CP-COV03 (a niclosamide-based inorganic nanohybrid product) against severe fever with thrombocytopenia syndrome virus in an in vitro model","volume":"12","author":"Han","year":"2024","journal-title":"Microbiol Spectr"},{"key":"B199","doi-asserted-by":"publisher","first-page":"142955","DOI":"10.1016\/j.ijbiomac.2025.142955","article-title":"Gn-modified biomimetic nanospheres for targeted siRNA delivery and their in vitro activity against severe fever with thrombocytopenia syndrome virus","volume":"309","author":"Wang","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2013.03.008","article-title":"The polymerase of negative-stranded RNA viruses","volume":"3","author":"Morin","year":"2013","journal-title":"Curr Opin Virol"},{"key":"B201","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.celrep.2019.12.020","article-title":"The cap-snatching SFTSV endonuclease domain is an antiviral target","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Rep"},{"key":"B202","doi-asserted-by":"publisher","first-page":"105230","DOI":"10.1016\/j.antiviral.2021.105230","article-title":"Screening and identification of Lassa virus endonuclease-targeting inhibitors from a fragment-based drug discovery library","volume":"197","author":"Lan","year":"2022","journal-title":"Antiviral Res"},{"key":"B203","doi-asserted-by":"crossref","DOI":"10.1038\/s41401-025-01533-7","article-title":"Identification of Licoflavone C as a cap-dependent endonuclease inhibitor against severe fever with thrombocytopenia syndrome virus","volume":"46","author":"Gao","year":"2025","journal-title":"Acta Pharmacol Sin"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1080\/1040841X.2018.1446901","article-title":"Bunyavirales ribonucleoproteins: the viral replication and transcription machinery","volume":"44","author":"Sun","year":"2018","journal-title":"Crit Rev Microbiol"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1578844","article-title":"Identification of lurasidone as a potent inhibitor of severe fever with thrombocytopenia syndrome virus by targeting the viral nucleoprotein","volume":"16","author":"Cheng","year":"2025","journal-title":"Front Microbiol"},{"key":"B206","doi-asserted-by":"publisher","first-page":"e1009129","DOI":"10.1371\/journal.ppat.1009129","article-title":"Host restriction of emerging high-pathogenic bunyaviruses via MOV10 by targeting viral nucleoprotein and blocking ribonucleoprotein assembly","volume":"16","author":"Mo","year":"2020","journal-title":"PloS Pathog"},{"key":"B207","doi-asserted-by":"publisher","first-page":"e0156823","DOI":"10.1128\/jvi.01568-23","article-title":"Host factor MxA restricts Dabie bandavirus infection by targeting the viral NP protein to inhibit NP-RdRp interaction and ribonucleoprotein activity","volume":"98","author":"Chang","year":"2024","journal-title":"J Virol"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.202500296","article-title":"Rational design and bioactive screening of peptide inhibitors targeting host-pathogen interactions in severe fever with thrombocytopenia syndrome virus (SFTSV)","volume":"26","author":"Hu","year":"2025","journal-title":"Chembiochem Eur J Chem Biol"},{"key":"B209","doi-asserted-by":"publisher","first-page":"20857","DOI":"10.1038\/s41598-021-00294-7","article-title":"Potential efficacy of existing drug molecules against severe fever with thrombocytopenia syndrome virus: an in silico study","volume":"11","author":"Chatterjee","year":"2021","journal-title":"Sci Rep"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1039\/D1RA06702H","article-title":"Virtual screening of phytochemicals from Indian medicinal plants against the endonuclease domain of SFTS virus L polymerase","volume":"12","author":"Vivek-Ananth","year":"2022","journal-title":"RSC Adv"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.3390\/v13102047","article-title":"In silico structure-based design of antiviral peptides targeting the severe fever with thrombocytopenia syndrome virus glycoprotein gn","volume":"13","author":"Yuan","year":"2021","journal-title":"Viruses"},{"key":"B212","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/j.chembiol.2024.10.009","article-title":"Host specific sphingomyelin is critical for replication of diverse RNA viruses","volume":"31","author":"Han","year":"2024","journal-title":"Cell Chem Biol"},{"key":"B213","doi-asserted-by":"publisher","first-page":"105164","DOI":"10.1016\/j.antiviral.2021.105164","article-title":"Peptides derived from viral glycoprotein Gc Inhibit infection of severe fever with thrombocytopenia syndrome virus","volume":"194","author":"Gao","year":"2021","journal-title":"Antiviral Res"},{"key":"B214","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41591-024-03434-4","article-title":"Artificial intelligence in drug development","volume":"31","author":"Zhang","year":"2025","journal-title":"Nat Med"},{"key":"B215","doi-asserted-by":"publisher","first-page":"e0285673","DOI":"10.1371\/journal.pone.0285673","article-title":"Knockout of CLTC gene reduces but not completely block SFTSV infection","volume":"18","author":"Liu","year":"2023","journal-title":"PloS One"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.977382","article-title":"Dual-gene detection in a single-tube system based on CRISPR-Cas12a\/Cas13a for severe fever thrombocytopenia syndrome virus","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Microbiol"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1039\/D2SC04656C","article-title":"Live-cell RNA imaging using the CRISPR-dCas13 system with modified sgRNAs appended with fluorescent RNA aptamers","volume":"13","author":"Tang","year":"2022","journal-title":"Chem Sci"},{"key":"B218","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.tips.2013.11.006","article-title":"Current progress in antiviral strategies","volume":"35","author":"Lou","year":"2014","journal-title":"Trends Pharmacol Sci"},{"key":"B219","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/s12916-022-02558-z","article-title":"Antiviral activity and mechanism of the antifungal drug, anidulafungin, suggesting its potential to promote treatment of viral diseases","volume":"20","author":"Shen","year":"2022","journal-title":"BMC Med"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.735223","article-title":"Screening of a small molecule compound library identifies toosendanin as an inhibitor against bunyavirus and SARS-coV-2","volume":"12","author":"Li","year":"2021","journal-title":"Front Pharmacol"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.3390\/v16081332","article-title":"Antiviral activity of selective estrogen receptor modulators against severe fever with thrombocytopenia syndrome virus in vitro and in vivo","volume":"16","author":"Yan","year":"2024","journal-title":"Viruses"},{"key":"B222","doi-asserted-by":"publisher","first-page":"111807","DOI":"10.1016\/j.cellsig.2025.111807","article-title":"Hedgehog pathway inhibitor HhAntag suppresses virus infection via the GLI-S1PR axis","volume":"132","author":"Zhang","year":"2025","journal-title":"Cell Signal"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1016\/j.virs.2025.03.011","article-title":"Qingqi Guxue Decoction induces S cell cycle arrest to inhibit replication of severe fever with thrombocytopenia syndrome virus","volume":"40","author":"Shi","year":"2025","journal-title":"Virol Sin"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1038\/s44321-024-00026-0","article-title":"Inhibition of SFTSV replication in humanized mice by a subcutaneously administered anti-PD1 nanobody","volume":"16","author":"Ji","year":"2024","journal-title":"EMBO Mol Med"},{"key":"B225","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ijid.2022.03.038","article-title":"Impact of glycemia and insulin treatment in fatal outcome of severe fever with thrombocytopenia syndrome","volume":"119","author":"Ge","year":"2022","journal-title":"Int J Infect Dis IJID Off Publ Int Soc Infect Dis"},{"key":"B226","doi-asserted-by":"publisher","first-page":"eaat4162","DOI":"10.1126\/scitranslmed.aat4162","article-title":"Arginine deficiency is involved in thrombocytopenia and immunosuppression in severe fever with thrombocytopenia syndrome","volume":"10","author":"Li","year":"2018","journal-title":"Sci Transl Med"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-024-01801-y","article-title":"Taurolithocholic acid protects against viral haemorrhagic fever via inhibition of ferroptosis","volume":"9","author":"Zheng","year":"2024","journal-title":"Nat Microbiol"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00634-25","article-title":"Metformin as antiviral therapy protects hyperglycemic and diabetic patients","volume":"16","author":"Wang","year":"2025","journal-title":"mBio"},{"key":"B229","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1186\/s12916-024-03672-w","article-title":"Serum lipidome reveals lipid metabolic dysregulation in severe fever with thrombocytopenia syndrome","volume":"22","author":"Guo","year":"2024","journal-title":"BMC Med"},{"key":"B230","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12985-025-02818-3","article-title":"Analysis of the clinical\u00a0efficacy of CCBs in patients with severe fever with thrombocytopenia syndrome combined with hypertension","volume":"22","author":"Ge","year":"2025","journal-title":"Virol J"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2018.06.053","article-title":"The cholesterol, fatty acid and triglyceride synthesis pathways regulated by site 1 protease (S1P) are required for efficient replication of severe fever with thrombocytopenia syndrome virus","volume":"503","author":"Urata","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"B232","doi-asserted-by":"publisher","first-page":"e0012673","DOI":"10.1371\/journal.pntd.0012673","article-title":"Dyslipidemia in severe fever with thrombocytopenia syndrome patients: A retrospective cohort study","volume":"18","author":"Guo","year":"2024","journal-title":"PloS Negl Trop Dis"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1412263","article-title":"Lower serum LDL-C levels are associated with poor prognosis in severe fever with thrombocytopenia syndrome: a single-center retrospective cohort study","volume":"15","author":"Guo","year":"2024","journal-title":"Front Microbiol"},{"key":"B234","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12985-015-0412-3","article-title":"Combination effects of ribavirin and interferons on severe fever with thrombocytopenia syndrome virus infection","volume":"12","author":"Shimojima","year":"2015","journal-title":"Virol J"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1016\/j.virs.2022.01.014","article-title":"Tilorone confers robust in vitro and in vivo antiviral effects against severe fever with thrombocytopenia syndrome virus","volume":"37","author":"Yang","year":"2022","journal-title":"Virol Sin"},{"key":"B236","doi-asserted-by":"publisher","first-page":"106181","DOI":"10.1016\/j.jinf.2024.106181","article-title":"Effect of tocilizumab plus corticosteroid on clinical outcome in patients hospitalized with severe fever with thrombocytopenia syndrome: A randomized clinical trial","volume":"89","author":"Ge","year":"2024","journal-title":"J Infect"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202507764","article-title":"Protein spatial structure meets artificial intelligence: revolutionizing drug synergy-antagonism in precision medicine","volume":"12","author":"Lin","year":"2025","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"key":"B238","doi-asserted-by":"publisher","first-page":"3836","DOI":"10.1038\/s41467-019-11815-4","article-title":"Development of a SFTSV DNA vaccine that confers complete protection against lethal infection in ferrets","volume":"10","author":"Kwak","year":"2019","journal-title":"Nat Commun"},{"key":"B239","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.colsurfb.2017.07.059","article-title":"Nano-patterning of a stainless steel microneedle surface to improve the dip-coating efficiency of a DNA vaccine and its immune response","volume":"159","author":"Jung","year":"2017","journal-title":"Colloids Surf B Biointerfaces"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1914704116","article-title":"Cross-genotype protection of live-attenuated vaccine candidate for severe fever with thrombocytopenia syndrome virus in a ferret model","volume":"116","author":"Yu","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B241","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41541-018-0096-y","article-title":"Single dose of a rVSV-based vaccine elicits complete protection against severe fever with thrombocytopenia syndrome virus","volume":"4","author":"Dong","year":"2019","journal-title":"NPJ Vaccines"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12121403","article-title":"Safety, immunogenicity, and efficacy of a recombinant vesicular stomatitis virus vectored vaccine against severe fever with thrombocytopenia syndrome virus and heartland bandavirus","volume":"12","author":"Hicks","year":"2024","journal-title":"Vaccines"},{"key":"B243","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41541-024-00993-y","article-title":"Adenovirus type 5-expressing Gn induces better protective immunity than Gc against SFTSV infection in mice","volume":"9","author":"Qian","year":"2024","journal-title":"NPJ Vaccines"},{"key":"B244","doi-asserted-by":"publisher","first-page":"109076","DOI":"10.1016\/j.vetmic.2021.109076","article-title":"A rabies virus vectored severe fever with thrombocytopenia syndrome (SFTS) bivalent candidate vaccine confers protective immune responses in mice","volume":"257","author":"Tian","year":"2021","journal-title":"Vet Microbiol"},{"key":"B245","doi-asserted-by":"publisher","first-page":"e1008859","DOI":"10.1371\/journal.ppat.1008859","article-title":"A highly attenuated vaccinia virus strain LC16m8-based vaccine for severe fever with thrombocytopenia syndrome","volume":"17","author":"Yoshikawa","year":"2021","journal-title":"PloS Pathog"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15051339","article-title":"An mRNA-based multiple antigenic gene expression system delivered by engineered salmonella for severe fever with thrombocytopenia syndrome and assessment of its immunogenicity and protection using a human DC-SIGN-transduced mouse model","volume":"15","author":"Park","year":"2023","journal-title":"Pharmaceutics"},{"key":"B247","doi-asserted-by":"publisher","first-page":"126524","DOI":"10.1016\/j.vaccine.2024.126524","article-title":"Development of a candidate vaccine against severe fever with thrombocytopenia syndrome virus using Gn\/Gc glycoprotein via multiple expression vectors delivered by attenuated Salmonella confers effective protection in hDC-SIGN transduced mice","volume":"43","author":"Park","year":"2025","journal-title":"Vaccine"},{"key":"B248","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev-med-042420-112725","article-title":"mRNA vaccines in the COVID-19 pandemic and beyond","volume":"73","author":"Hogan","year":"2022","journal-title":"Annu Rev Med"},{"key":"B249","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41541-023-00771-2","article-title":"mRNA vaccine encoding Gn provides protection against severe fever with thrombocytopenia syndrome virus in mice","volume":"8","author":"Kim","year":"2023","journal-title":"NPJ Vaccines"},{"key":"B250","doi-asserted-by":"publisher","first-page":"e0076924","DOI":"10.1128\/jvi.00769-24","article-title":"A full-length glycoprotein mRNA vaccine confers complete protection against severe fever with thrombocytopenia syndrome virus, with broad-spectrum protective effects against bandaviruses","volume":"98","author":"Lu","year":"2024","journal-title":"J Virol"},{"key":"B251","doi-asserted-by":"publisher","first-page":"e0012815","DOI":"10.1371\/journal.pntd.0012815","article-title":"Development of a novel multi-epitope mRNA vaccine candidate to combat SFTSV pandemic","volume":"19","author":"Zhu","year":"2025","journal-title":"PloS Negl Trop Dis"},{"key":"B252","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12883-024-03664-6","article-title":"Severe fever with thrombocytopenia syndrome with central nervous system symptom onset: a case report and literature review","volume":"24","author":"Shan","year":"2024","journal-title":"BMC Neurol"},{"key":"B253","doi-asserted-by":"publisher","first-page":"116350","DOI":"10.1016\/j.diagmicrobio.2024.116350","article-title":"The first diagnosis of Severe Fever with Thrombocytopenia Syndrome caused by tick-borne Severe Fever with Thrombocytopenia Syndrome virus in Chongqing, China: A case report and literature review","volume":"109","author":"Hu","year":"2024","journal-title":"Diagn Microbiol Infect Dis"},{"key":"B254","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12879-025-10503-7","article-title":"Severe fever with thrombocytopenia syndrome complicated with aspergillus endocarditis and multiple organ infarctions after glucocorticoid treatment in an immunocompetent man: a case report","volume":"25","author":"Zhao","year":"2025","journal-title":"BMC Infect Dis"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28059","article-title":"Associated microbiota and treatment of severe fever with thrombocytopenia syndrome complicated with infections","volume":"94","author":"Zhang","year":"2022","journal-title":"J Med Virol"},{"key":"B256","doi-asserted-by":"publisher","first-page":"104993","DOI":"10.1016\/j.antiviral.2020.104993","article-title":"The NF-\u03baB inhibitor, SC75741, is a novel antiviral against emerging tick-borne bandaviruses","volume":"185","author":"Mendoza","year":"2021","journal-title":"Antiviral Res"},{"key":"B257","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.772802","article-title":"Development and characterization of a reverse genetics system for a human-derived severe fever with thrombocytopenia syndrome virus isolate from South Korea","volume":"12","author":"Yun","year":"2021","journal-title":"Front Microbiol"},{"key":"B258","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.03432-14","article-title":"Reverse genetics system for severe fever with thrombocytopenia syndrome virus","volume":"89","author":"Brennan","year":"2015","journal-title":"J Virol"},{"key":"B259","doi-asserted-by":"publisher","DOI":"10.3390\/v15051147","article-title":"Construction and characterization of severe fever with thrombocytopenia syndrome virus with a fluorescent reporter for antiviral drug screening","volume":"15","author":"Wang","year":"2023","journal-title":"Viruses"},{"key":"B260","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.03511-14","article-title":"Generation of mutant Uukuniemi viruses lacking the nonstructural protein NSs by reverse genetics indicates that NSs is a weak interferon antagonist","volume":"89","author":"Rezelj","year":"2015","journal-title":"J Virol"},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00743-17","article-title":"Mapping of transcription termination within the S segment of SFTS phlebovirus facilitated generation of NSs deletant viruses","volume":"91","author":"Brennan","year":"2017","journal-title":"J Virol"},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.7150\/thno.75123","article-title":"Recapitulating influenza virus infection and facilitating antiviral and neuroprotective screening in tractable brain organoids","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"key":"B263","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.6645","article-title":"18F-FDG PET imaging for identifying the dynamics of intestinal disease caused by SFTSV infection in a mouse model","volume":"7","author":"Hayasaka","year":"2016","journal-title":"Oncotarget"},{"key":"B264","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1531880","article-title":"Fatal risk factors and the efficacy of glucocorticoid therapy in severe fever with thrombocytopenia syndrome: a multicenter retrospective cohort study","volume":"15","author":"Zhong","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"B265","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12985-025-02651-8","article-title":"Establishment and validation of a dynamic nomogram to predict short-term prognosis and benefit of human immunoglobulin therapy in patients with novel bunyavirus sepsis in a population analysis study: a multicenter retrospective study","volume":"22","author":"Yang","year":"2025","journal-title":"Virol J"},{"key":"B266","doi-asserted-by":"publisher","first-page":"2498572","DOI":"10.1080\/22221751.2025.2498572","article-title":"A machine learning model for mortality prediction in patients with severe fever with thrombocytopenia syndrome: a prospective, multicenter cohort study","volume":"14","author":"Liu","year":"2025","journal-title":"Emerg Microbes Infect"},{"key":"B267","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2022.12.007","article-title":"Haemaphysalis longicornis (Asian longhorned tick)","volume":"39","author":"Yabsley","year":"2023","journal-title":"Trends Parasitol"},{"key":"B268","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.15-0047","article-title":"Phylogenetic analysis of severe fever with thrombocytopenia syndrome virus in South Korea and migratory bird routes between China, South Korea, and Japan","volume":"93","author":"Yun","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"B269","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2024.2370965","article-title":"Serologic evidence of human exposure to the severe fever with thrombocytopenia syndrome virus and associated viruses in Kenya","volume":"56","author":"Zohaib","year":"2024","journal-title":"Infect Dis Lond Engl"},{"key":"B270","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12020286","article-title":"Heartland virus disease-an underreported emerging infection","volume":"12","author":"Dembek","year":"2024","journal-title":"Microorganisms"},{"key":"B271","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3390\/v17020232","article-title":"Emerging arboviral diseases in Pakistan: epidemiology and public health implications","volume":"17","author":"Ammar","year":"2025","journal-title":"Viruses"},{"key":"B272","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1423181\/full","article-title":"Knowledge mapping of severe fever with thrombocytopenia syndrome: a bibliometric analysis","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Microbiol"},{"key":"B273","doi-asserted-by":"publisher","first-page":"e89896","DOI":"10.1371\/journal.pone.0089896","article-title":"Co-circulation of multiple hemorrhagic fever diseases with distinct clinical characteristics in Dandong, China","volume":"9","author":"Chen","year":"2014","journal-title":"PloS One"},{"key":"B274","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02068-18","article-title":"M segment-based minigenomes and virus-like particle assays as an approach to assess the potential of tick-borne phlebovirus genome reassortment","volume":"93","author":"Rezelj","year":"2019","journal-title":"J Virol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1730089\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T06:39:59Z","timestamp":1769495999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1730089\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":274,"alternative-id":["10.3389\/fimmu.2026.1730089"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1730089","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"article-number":"1730089"}}